JP2003525906A5 - - Google Patents

Download PDF

Info

Publication number
JP2003525906A5
JP2003525906A5 JP2001564783A JP2001564783A JP2003525906A5 JP 2003525906 A5 JP2003525906 A5 JP 2003525906A5 JP 2001564783 A JP2001564783 A JP 2001564783A JP 2001564783 A JP2001564783 A JP 2001564783A JP 2003525906 A5 JP2003525906 A5 JP 2003525906A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
seq
compound
fragment
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001564783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003525906A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IT2000/000072 external-priority patent/WO2001066131A1/en
Publication of JP2003525906A publication Critical patent/JP2003525906A/ja
Publication of JP2003525906A5 publication Critical patent/JP2003525906A5/ja
Withdrawn legal-status Critical Current

Links

JP2001564783A 2000-03-06 2000-03-06 高レベルのアロマターゼにより特徴付けられる疾患の治療のためのインターロイキン−6アンタゴニストの使用 Withdrawn JP2003525906A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (2)

Publication Number Publication Date
JP2003525906A JP2003525906A (ja) 2003-09-02
JP2003525906A5 true JP2003525906A5 (https=) 2007-04-26

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001564783A Withdrawn JP2003525906A (ja) 2000-03-06 2000-03-06 高レベルのアロマターゼにより特徴付けられる疾患の治療のためのインターロイキン−6アンタゴニストの使用

Country Status (17)

Country Link
US (1) US7160860B2 (https=)
EP (1) EP1261367B1 (https=)
JP (1) JP2003525906A (https=)
KR (1) KR100694005B1 (https=)
AT (1) ATE295735T1 (https=)
AU (1) AU2000233235A1 (https=)
CA (1) CA2400711A1 (https=)
CZ (1) CZ20022760A3 (https=)
DE (1) DE60020269T2 (https=)
DK (1) DK1261367T3 (https=)
ES (1) ES2241583T3 (https=)
HU (1) HUP0300117A3 (https=)
MX (1) MXPA02008697A (https=)
PL (1) PL356846A1 (https=)
PT (1) PT1261367E (https=)
SK (1) SK12412002A3 (https=)
WO (1) WO2001066131A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
EP2471493A1 (en) 2008-01-17 2012-07-04 Synthes GmbH An expandable intervertebral implant and associated method of manufacturing the same
CN102036623A (zh) 2008-04-05 2011-04-27 斯恩蒂斯有限公司 可膨胀的椎间植入体
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
US9282979B2 (en) 2010-06-24 2016-03-15 DePuy Synthes Products, Inc. Instruments and methods for non-parallel disc space preparation
AU2011271465B2 (en) 2010-06-29 2015-03-19 Synthes Gmbh Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
WO2014018098A1 (en) 2012-07-26 2014-01-30 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
WO2018002715A2 (en) 2016-06-28 2018-01-04 Eit Emerging Implant Technologies Gmbh Expandable and angularly adjustable articulating intervertebral cages
EP3474783B1 (en) 2016-06-28 2023-05-03 Eit Emerging Implant Technologies GmbH Expandable, angularly adjustable intervertebral cages
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Similar Documents

Publication Publication Date Title
JP2003525906A5 (https=)
Simpson et al. Aromatase and its inhibitors: significance for breast cancer therapy
Yan et al. Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer
Torres et al. Liver‐specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation
WO1999046279A3 (en) INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
UA92348C2 (en) 17b-HSD1 AND STS INHIBITORS
Lewis-Wambi et al. Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs)
Kang et al. Transcriptional inactivation of the tissue inhibitor of metalloproteinase‐3 gene by dna hypermethylation of the 5'‐CpG island in human gastric cancer cell lines
BRPI0413930A (pt) composto oligomérico ou sal farmaceuticamente aceitável deste, composição farmacêutica ou veterinária, métodos para inibir a expressão de eif4e em uma célula, tecido ou órgão, para diminuir a proliferação de uma célula em que eif4e é expressado, e para prevenir ou tratar uma condição ou doença métodos para prevenir ou diminuir a angiogênese, e o crescimento de tumor em um paciente, oligonucleotìdeo de anti-sentido, composição farmacêutica ou veterinária, e, uso de um composto oligomérico ou sal farmaceuticamente aceitável deste
MY131522A (en) PHARMACEUTICAL COMPOSITION AND USES FOR ANDROST-5-ENE-3ß,17ß-DIOL
JP2004511201A5 (https=)
WO2006124012A3 (en) Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production
IL161177A0 (en) Pharmaceutical preparation useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
US20020035098A1 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
CA2375467C (en) Antisense therapy for hormone-regulated tumors
Yang et al. Kaempferol stimulates bone sialoprotein gene transcription and new bone formation
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
JP2003528919A5 (https=)
Marreiros et al. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53
Brueggemeier Biochemical and molecular aspects of aromatase
WO2005058934A3 (en) Glycosylated steroid derivatives with anti-migratory activity
MXPA02000680A (es) Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
Reed Oestradiol-17β hydroxysteroid dehydrogenase: its family and function
WO2002074315A8 (de) Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie